From Gut Dysbiosis to Skin Inflammation in Atopic Dermatitis: Probiotics and the Gut–Skin Axis—Clinical Outcomes and Microbiome Implications
International Journal of Molecular Sciences · 29.12.2025 · 27 (1) · 365
DOI: 10.3390/ijms27010365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.12.2025. Verfasst von Adina Elena Micu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Probiotics, Dysbiosis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which barrier impairment, immune dysregulation, and gut–skin dysbiosis intersect, prompting growing interest in probiotics as microbiota-modulating adjuncts. We conducted a narrative review of peer-reviewed articles indexed in PubMed, Scopus, and Google Scholar, restricted to publications from 1 January 2018 to 31 October 2025 (searches last run in December 2025). Eligible evidence included randomized controlled trials (RCTs), observational studies, and mechanistic or conceptual reviews addressing microbiome alterations and microbiota-modulating interventions in AD. Most pediatric RCTs using multistrain, Lactobacillus-dominant formulations (often combined with Bifidobacterium) reported modest improvements in AD severity and pruritus and in selected barrier- and inflammation-related biomarkers. However, direct cutaneous microbiome “restoration” outcomes were reported in a minority of studies, and most clinical evidence relies on clinical endpoints and gut–skin axis plausibility rather than longitudinal skin microbiome readouts. Single-strain regimens showed inconsistent effects, and evidence in adolescents and adults remained heterogeneous. Mechanistically, probiotics may enhance short-chain fatty acid (SCFA) signaling, dampen toll-like receptor 2/4 (TLR2/4)-nuclear factor kappa B (NF-κB) activation, and promote interleukin-10 (IL-10)- and transforming growth factor-β (TGF-β)-driven tolerance. Probiotics are a biologically plausible adjunct targeting the gut–skin axis in AD and are generally well tolerated; however, heterogeneity across trials, limited follow-up, inconsistent adverse-event reporting, and scarce skin microbiome endpoints preclude firm clinical recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.
- Department of Dermatology, "St. Spiridon" Emergency County Clinical Hospital, 700111 Iași, Romania.
ORCID-Profile: Ioana Adriana Popescu, Ioana Alina Halip
Zitieren
APA
Micu, A. E., Popescu, I. A., Halip, I. A., Mocanu, M., Vâță, D., Hulubencu, A. L., Gheucă-Solovăstru, D. F., & Gheucă-Solovăstru, L. (2025). From Gut Dysbiosis to Skin Inflammation in Atopic Dermatitis: Probiotics and the Gut–Skin Axis—Clinical Outcomes and Microbiome Implications. International Journal of Molecular Sciences, 27(1), 365. https://doi.org/10.3390/ijms27010365
Vancouver
Micu AE, Popescu IA, Halip IA, Mocanu M, Vâță D, Hulubencu AL, et al. From Gut Dysbiosis to Skin Inflammation in Atopic Dermatitis: Probiotics and the Gut–Skin Axis—Clinical Outcomes and Microbiome Implications. International Journal of Molecular Sciences. 2025;27(1):365. doi:10.3390/ijms27010365
BibTeX
@article{Micu2025,
author = {Micu, Adina Elena and Popescu, Ioana Adriana and Halip, Ioana Alina and Mocanu, Mădălina and Vâță, Dan and Hulubencu, Andreea Luana and Gheucă-Solovăstru, Dragoș Florin and Gheucă-Solovăstru, Laura},
title = {From Gut Dysbiosis to Skin Inflammation in Atopic Dermatitis: Probiotics and the Gut–Skin Axis—Clinical Outcomes and Microbiome Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {27},
number = {1},
pages = {365},
doi = {10.3390/ijms27010365}
}
EUVIMED